Form 4: Tenon Medical Director Reports Stock Transaction
Insider Transaction (Form 4)
Kristine M Jacques, a Director of Tenon Medical, Inc., reported multiple transactions in common stock on July 31, 2026.
Summary
- Option exercise/conversion: acquired 10,147 Common Stock on July 31, 2026; holds 20,876 after (Direct).
- Option exercise/conversion: disposed of 10,147 Restricted Stock Units on July 31, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kristine M Jacques — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Option exercise/conversion | Common Stock | 10,147 | — | — | 20,876 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 10,147 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Option exercise/conversion (10,147 shares) |
| 2026-07-31 | Option exercise/conversion (10,147 shares) |
Keywords
insider transaction, Form 4, TNON, Tenon Medical, Inc., neutral, Kristine M Jacques
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.